Related Experiment Video
Updated: Sep 10, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Ischaemic mitral regurgitation in coronary revascularization: A critical gap in surgical guidelines
1Department of CTVS, ABVIMS and Dr RML Hospital, New Delhi, 110001, India.
Insights
Managing ischemic mitral regurgitation (IMR) with coronary artery disease (CAD) remains complex. Current evidence offers mixed results on surgical interventions, necessitating clearer guidelines for optimal patient outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Medicine
Background:
- Ischemic mitral regurgitation (IMR) poses a significant clinical challenge, especially when co-occurring with coronary artery disease (CAD).
- Treatment paradigms for IMR are evolving, yet controversies persist regarding the optimal surgical approach, leading to a lack of definitive clinical guidelines.
- The management of IMR requires careful consideration due to its complexity and the ongoing debate surrounding surgical interventions.
Purpose of the Study:
- To review and analyze the evolving discourse and treatment landscape for ischemic mitral regurgitation (IMR) from 2000 to 2020.
- To elucidate the impact of various interventions, including coronary revascularization and mitral valve procedures, on patient outcomes in IMR.
- To identify the persistent ambiguities in IMR management guidelines and the need for evidence-based recommendations.
Main Methods:
- A comprehensive literature review of seminal studies published between 2000 and 2020 was conducted.
- Studies focusing on interventions for IMR, such as coronary artery bypass grafting (CABG) with or without mitral valve intervention, were critically evaluated.
- Data on patient outcomes, adverse events, and recurrence rates following different surgical approaches were scrutinized.
Main Results:
- Early studies presented conflicting views on the necessity of adjunct mitral valve intervention during CABG for IMR.
- Subsequent trials (e.g., POINT, RIME) suggested benefits of concomitant mitral interventions, while the Cardiothoracic Surgical Trials Network (CTSN) trials raised concerns about adverse events and repair durability.
- Current guidelines from organizations like the American Heart Association (AHA) offer moderate support but lack a clear consensus on mitral valve interventions for IMR.
Conclusions:
- The optimal surgical management for ischemic mitral regurgitation (IMR) in patients with coronary artery disease (CAD) remains controversial.
- Despite some evidence supporting concomitant mitral interventions, concerns regarding adverse events and recurrence persist, contributing to guideline ambiguity.
- There is an imperative need for refined clinical guidelines based on current evidence to optimize treatment strategies and improve outcomes for IMR patients.
Abstract:
Ischemic mitral regurgitation (IMR) presents a clinical challenge amidst evolving treatment paradigms, particularly when accompanied by coronary artery disease (CAD). Controversies persist regarding the optimal surgical approach, resulting in a lack of definitive guidelines. A comprehensive review of seminal studies from 2000 to 2020 was conducted to elucidate the evolving discourse and treatment landscape for IMR. Studies encompassing varied interventions, including coronary revascularization and concomitant mitral valve procedures, were scrutinized to gauge their impact on patient outcomes. Early studies diverged in advocating for or against adjunct mitral valve intervention during coronary artery bypass grafting (CABG) in IMR patients. Subsequent trials like the POINT and RIME trials highlighted benefits associated with concomitant mitral interventions. However, the Cardiothoracic Surgical Trials Network (CTSN) trials raised concerns regarding adverse events and recurrence rates post-mitral repair.The ambiguity in guidelines for IMR management persists, leaving surgeons to navigate individualized treatment decisions. Recommendations from the American Heart Association (AHA) offer moderate support for mitral valve interventions, yet a clear consensus remains elusive. The necessity for refined guidelines reflecting current evidence is imperative to optimize outcomes in IMR patients.
More Related Videos
08:12Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management